Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dean Slagel Insider Profile
4 Followers
Dean Slagel, Director at Cara Therapeutics, holds 1.31M shares in Cara Therapeutics (Ticker: CARA).
Dean Slagel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Dean Slagel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dean Slagel
Dean Slagel's Trading History
List of latest transactions for each holding click on a transaction to see Dean Slagel's performance on stock
You May Also Like
Dean Slagel insider profile FAQ
What is the percentage of profitable transactions made by Dean Slagel?
The percentage of profitable transactions made by Dean Slagel is ―.
What is the average return per transaction made by Dean Slagel?
The average return per transaction made by Dean Slagel is ―.
What stocks does Dean Slagel hold?
Dean Slagel holds: CARA stocks.
What was Dean Slagel’s latest transaction?
Dean Slagel latest transaction was an Uninformative Sell of $6.47M.
What was Dean Slagel's most profitable transaction?
Dean Slagel’s most profitable transaction was an Informative Sell of CARA stock on May 19, 2015. The return on the trade was 45.00%.
What is Dean Slagel's role in Cara Therapeutics?
Dean Slagel's role in Cara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.